Showing 531-540 of 685 results for "".
- Kenvue Introduces Patented Micro-Peptide Technology with Neutrogena Collagen Bank Launchhttps://modernaesthetics.com/news/kenvue-introduces-patented-micro-peptide-technology-with-neutrogena-collagen-bank-launch/2473651/Kenvue announced the launch of Neutrogena Collagen Bank featuring the company’s patented micro-peptide technology. The launch brings Neutrogena into the pre-aging catefory and is poised to meet the needs of Gen Z, a new generation of consumers. Neutrogena Collagen Bank aims
- L’Oréal Eyes Aesthetics Market with Acquisition of Minority Stake in Galdermahttps://modernaesthetics.com/news/loreal-eyes-aesthetics-market-with-acquisition-of-galderma/2473646/Major beauty brand L’Oréal announced the acquisition of a 10% stake in Galderma, a Swiss pharmaceutical company. The two companies have agreed to work towards a strategic scientific partnership that will leverage the undisputed expertise of both companies, according to a press releas
- Dermal Fillers Global Marketing Rising in Demandhttps://modernaesthetics.com/news/dermal-fillers-global-marketing-rising-in-demand/2473640/The dermal fillers global market size is expected to grow from almost $4 billion over the next seven years, reaching an estimated $7.58 billion by 2031. It’s anticipated to register a compound annual growth rate of 8.3% during the forecasted period, according to Premium Market Insights.&nbs
- Allergen Aesthetics Brings Back JUVÉDERM® Dayhttps://modernaesthetics.com/news/allergen-aesthetics-brings-back-juvederm-day/2473639/Allergan Aesthetics announced the return of JUVÉDERM® Day on Wednesday, August 21. The event, held for the first time last year, features limited-time offers, savings, and exclusive deals through Allē, the Allergan Aesthetics loyalty rewards program.
- First, Only US Neurotoxin for Simultaneous Treatment of Upper Facial Lines Gets FDA Approvalhttps://modernaesthetics.com/news/first-only-us-neurotoxin-for-simultaneous-treatment-of-upper-facial-lines-gets-fda-approval/2473638/Merz Aesthetics announced the US Food and Drug Administration approved XEOMIN (incobotulinumtoxinA) as the first and only neurotoxin for the simultaneous treatment of upper facial lines – forehead lines, frown lines, and crow’s feet. XEOMIN was first approved in 2011 f
- Aesthetic Lasers and Energy Devices Market Size to Grow By $2.37Bhttps://modernaesthetics.com/news/aesthetic-lasers-and-energy-devices-market-size-to-grow-by-237b-5/2473637/The global aesthetics laser and energy devices market size is estimated to grow by $2.37 billion from 2024 to 2028. Technavio report the market will grow at a compound annual growth rate of almost 10.87% during the next four years. A key factor driving growth in the market is the
- DefenAge Skincare Launches New Patented Skin Regeneration Technologyhttps://modernaesthetics.com/news/defenage-skincare-launches-new-patented-skin-regeneration-technology/2473630/DefenAge Skincare announced a new skin regeneration technology with the acquisition of a new patent using a regenerative approach for skin care and wound healing. The company says the cutting-edge technology is now available for licensing and product development partnerships, presenting an unpara
- US Leads North America Dermal Fillers Market Share, Asia-Pacific Region Forecasts Highest Growthhttps://modernaesthetics.com/news/us-leads-north-american-dermal-fillers-market-share-asia-pacific-region-shows-highest-growth/2473625/The Global Dermal Fillers Market – Focused Insights 2024-2029 determined the global dermal fillers market is expected to grow at a compound annual growth rate of 8.31% over the next five years. Research found the US dominated the dermal fillers market shar
- New Product Line for Hair, Scalp Introduced by Elevai Labs Inc.https://modernaesthetics.com/news/new-product-line-for-hair-scalp-introduced-by-elevai-labs-inc/2473616/Elevai Skincare, a subsidiary of Elevai Labs Inc., announced the Elevai S-Series, a hair and scalp product line. The three-part hair and scalp care system combines the power of exosomes with advanced mitochondrial technology. The product incorporates Elevai’s proprietary pre
- Incredible Marketing Teams Up with PatientNow as Exclusive Digital Marketing Providerhttps://modernaesthetics.com/news/incredible-marketing-teams-up-with-patientnow-as-exclusive-digital-marketing-provider/2473614/Incredible Marketing announced a new partnership with PatientNow, a premier provider of practice management solutions for the medical aesthetics sector. The company describes the alliance as the digital marketing provider for all PatientNow clients and designates PatientNow as the preferred pract